Literature DB >> 22027293

Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?

Lutz Heinemann, Solomon Steiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22027293      PMCID： PMC3208856          DOI： 10.1177/193229681100500501

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  11 in total

1.  Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.

Authors:  Ronald J Pettis; Barry Ginsberg; Laurence Hirsch; Diane Sutter; Steven Keith; Elaine McVey; Noel G Harvey; Marcus Hompesch; Leszek Nosek; Christoph Kapitza; Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2011-02-28       Impact factor: 6.118

2.  Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs.

Authors:  Alfred J Harvey; Scott A Kaestner; Diane E Sutter; Noel G Harvey; John A Mikszta; Ronald J Pettis
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

3.  Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.

Authors:  Lutz Heinemann; Marcus Hompesch; Frank Flacke; Patrick Simms; Rody Pohl; Kerstin Albus; Andreas Pfützner; Solomon Steiner
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

Review 4.  Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?

Authors:  Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

5.  Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.

Authors:  Ronald J Pettis; Laurence Hirsch; Christoph Kapitza; Leszek Nosek; Ulrike Hövelmann; Heinz-Joerg Kurth; Diane E Sutter; Noel G Harvey; Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2011-02-28       Impact factor: 6.118

6.  Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.

Authors:  Karena L Swan; James D Dziura; Garry M Steil; Gayane R Voskanyan; Kristin A Sikes; Amy T Steffen; Melody L Martin; William V Tamborlane; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

7.  Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

Authors:  Yoeri M Luijf; Arianne C van Bon; Joost B Hoekstra; J Hans Devries
Journal:  Diabetes Care       Date:  2010-08-06       Impact factor: 19.112

8.  The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.

Authors:  T Kobayashi; S Sawano; T Itoh; K Kosaka; H Hirayama; Y Kasuya
Journal:  Diabetes       Date:  1983-04       Impact factor: 9.461

9.  Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man.

Authors:  W K Waldhäusl; P R Bratusch-Marrain; H Vierhapper; P Nowotny
Journal:  Metabolism       Date:  1983-05       Impact factor: 8.694

10.  A novel insulin formulation with a more rapid onset of action.

Authors:  S Steiner; M Hompesch; R Pohl; P Simms; F Flacke; T Mohr; A Pfützner; L Heinemann
Journal:  Diabetologia       Date:  2008-07-19       Impact factor: 10.122
View more
  3 in total

Review 1.  Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion.

Authors:  Lutz Heinemann; Lars Krinelke
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

2.  Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators.

Authors:  John Walsh; Ruth Roberts; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

3.  Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump.

Authors:  Mauro Boronat; Rosa M Sánchez-Hernández; Julia Rodríguez-Cordero; Angelines Jiménez-Ortega; Francisco J Nóvoa
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.